Notice of Extraordinary General Meeting and Proxy Form
Released
Released
Announcement PDF
5 March 2026
Dear Shareholder,
WEST WITS MINING LIMITED – EXTRAORDINARY GENERAL MEETING
West Wits Mining Limited (the Company) advises that an Extraordinary General Meeting of the
shareholders of the Company (Shareholders) is scheduled to be held at the offices of William Buck,
Level 20, 181 William Street, Melbourne VIC 3000 on 8 April 2026 at 3:00pm (Melbourne time) (the
Meeting).
The Company will not be despatching physical copies of the Notice of Extraordinary General Meeting
(Notice of Meeting) unless a Shareholder has requested a physical copy or made an election to receive
document from the Company in physical form. Instead, the Notice of Meeting can be viewed, accessed
and downloaded via the following direct link to the ASX announcements platform of the Company:
https://www.asx.com.au/markets/trade-our-cash-market/announcements.wwi
Shareholders are strongly encouraged to vote by lodging a directed proxy appointing the Chairperson
of the Meeting before 3.00pm (Melbourne time) on 6 April 2026. Proxies can be lodged in accordance
with the instructions on the personalised proxy form enclosed with this letter.
If it becomes necessary or appropriate to make alternative arrangements to those set out above and
in the Notice of Meeting the Company will announce the alternative arrangements to ASX.
Shareholders are encouraged to check for announcements of the Company at the ASX website
(https://www.asx.com.au), using the search code “WWI”.
The Company thanks shareholders for their ongoing support.
Simon Whyte
Joint Company Secretary and CFO
WEST WITS MINING LIMITED
ACN 124 894 060
NOTICE OF EXTRAORDINARY GENERAL MEETING
Notice is hereby given that an Extraordinary General Meeting (“Meeting”) of the shareholders of West Wits Mining Limited
[ACN 124 894 060] (“the Company”) will be held at the offices of William Buck, Level 20, 181 William Street, Melbourne
VIC 3000 on 8 April 2026 at 3:00pm (Melbourne time).
Further details in respect of each of the Resolutions proposed in this Notice of Extraordinary General Meeting (“Notice”) are
set out in the Explanatory Memorandum (“Memorandum”) accompanying this Notice. The details of Resolutions contained
in the Memorandum should be read together with, and form part of, this Notice.
AGENDA – NOTE ALL FIGURES ARE ON A PRE-CONSOLIDATION BASIS EXCEPT WHERE OTHERWISE STATED
RESOLUTION 1: RATIFICATION OF PRIOR ISSUE OF SHARES - PLACEMENT
To consider and, if thought fit, to pass the following Resolution as an ordinary resolution:
“That, for the purposes of Listing Rule 7.4 and for all other purposes, shareholders ratify the prior issue of 421,750,000
fully paid ordinary shares at an issue price of $0.08 (8 cents) per share to unrelated sophisticated and institutional
investors as described in the Memorandum which accompanied and formed part of this Notice.”
Voting Exclusion Statement – Resolution 1
The Company will disregard any votes cast in favour of Resolution 1 by or on behalf of a person who participated in the issue or is a
counterparty to the agreement being approved or any associate of that person.
However, this does not apply to a vote cast in favour of Resolution 1 by:
• a person as proxy or attorney for a person who is entitled to vote on the resolution, in accordance with the directions given to the
proxy or attorney to vote on the resolution in that way; or
• the chair of the Meeting as proxy or attorney for a person who is entitled to vote on the resolution, in accordance with a direction
given to the chair to vote on the resolution as the chair decides; or
• a holder acting solely as nominee, trustee, custodial or other fiduciary capacity on behalf of a beneficiary provided the following
conditions are met:
o the beneficiary provides written confirmation to the holder that the beneficiary is not excluded from voting, and is not an
associate of a person excluded from voting, on the resolution; and
o the holder votes on the resolution in accordance with directions given by the beneficiary to the holder to vote in that way.
RESOLUTION 2: RATIFICATION OF PRIOR ISSUE OF OPTIONS – PLACEMENT
To consider and, if thought fit, to pass the following Resolution as an ordinary resolution:
“That, for the purposes of Listing Rule 7.4 and for all other purposes, shareholders ratify the prior issue of 210,874,997
unlisted options (each with an exercise price of $0.11 (11 cents), expiring 27 January 2029 and which, upon exercise,
entitle the holder to one fully paid ordinary share in the capital of the Company) to unrelated sophisticated and
institutional investors who subscribed for the fully paid ordinary shares the subject of Resolution 1, as described in the
Memorandum which accompanied and formed part of this Notice.”
Voting Exclusion Statement – Resolution 2
The Company will disregard any votes cast in favour of Resolution 2 by or on behalf of a person who participated in the issue or is a
counterparty to the agreement being approved or any associate of that person.
However, this does not apply to a vote cast in favour of Resolution 2 by:
• a person as proxy or attorney for a person who is entitled to vote on the resolution, in accordance with the directions given to the
proxy or attorney to vote on the resolution in that way; or
-2-
• the chair of the Meeting as proxy or attorney for a person who is entitled to vote on the resolution, in accordance with a direction
given to the chair to vote on the resolution as the chair decides; or
• a holder acting solely as nominee, trustee, custodial or other fiduciary capacity on behalf of a beneficiary provided the following
conditions are met:
o the beneficiary provides written confirmation to the holder that the beneficiary is not excluded from voting, and is not an
associate of a person excluded from voting, on the resolution; and
o the holder votes on the resolution in accordance with directions given by the beneficiary to the holder to vote in that way.
RESOLUTION 3: RATIFICATION OF PRIOR ISSUE OF OPTIONS – EVOLUTION
To consider and, if thought fit, to pass the following Resolution as an ordinary resolution:
“That, for the purposes of Listing Rule 7.4 and for all other purposes, shareholders ratify the prior issue of 10,000,000
unlisted options (each with an exercise price of $0.11 (11 cents), expiring 27 January 2029 and which, upon exercise,
entitle the holder to one fully paid ordinary share in the capital of the Company) to Evolution Capital Pty Ltd as described
in the Memorandum which accompanied and formed part of this Notice.”
Voting Exclusion Statement – Resolution 3
The Company will disregard any votes cast in favour of Resolution 3 by or on behalf of a person who participated in the issue or is a
counterparty to the agreement being approved or any associate of that person.
However, this does not apply to a vote cast in favour of Resolution 3 by:
• a person as proxy or attorney for a person who is entitled to vote on the resolution, in accordance with the directions given to the
proxy or attorney to vote on the resolution in that way; or
• the chair of the Meeting as proxy or attorney for a person who is entitled to vote on the resolution, in accordance with a direction
given to the chair to vote on the resolution as the chair decides; or
• a holder acting solely as nominee, trustee, custodial or other fiduciary capacity on behalf of a beneficiary provided the following
conditions are met:
o the beneficiary provides written confirmation to the holder that the beneficiary is not excluded from voting, and is not an
associate of a person excluded from voting, on the resolution; and
o the holder votes on the resolution in accordance with directions given by the beneficiary to the holder to vote in that way.
RESOLUTION 4: RATIFICATION OF PRIOR ISSUE OF OPTIONS – ABSA
To consider and, if thought fit, to pass the following Resolution as an ordinary resolution:
“That, for the purposes of Listing Rule 7.4 and for all other purposes, shareholders ratify the prior issue of 100,386,000
unlisted options (each with an exercise price of $0.0185 (1.85 cents), expiring 30 November 2030 and which, upon
exercise, entitle the holder to one fully paid ordinary share in the capital of the Company) to Absa Bank Limited (acting
through its Corporate and Investment Banking Division) as described in the Memorandum which accompanied and
formed part of this Notice.”
Voting Exclusion Statement – Resolution 4
The Company will disregard any votes cast in favour of Resolution 4 by or on behalf of a person who participated in the issue or is a
counterparty to the agreement being approved or any associate of that person.
However, this does not apply to a vote cast in favour of Resolution 4 by:
• a person as proxy or attorney for a person who is entitled to vote on the resolution, in accordance with the directions given to the
proxy or attorney to vote on the resolution in that way; or
• the chair of the Meeting as proxy or attorney for a person who is entitled to vote on the resolution, in accordance with a direction
-3-
given to the chair to vote on the resolution as the chair decides; or
• a holder acting solely as nominee, trustee, custodial or other fiduciary capacity on behalf of a beneficiary provided the following
conditions are met:
o the beneficiary provides written confirmation to the holder that the beneficiary is not excluded from voting, and is not an
associate of a person excluded from voting, on the resolution; and
o the holder votes on the resolution in accordance with directions given by the beneficiary to the holder to vote in that way.
RESOLUTION 5: RATIFICATION OF PRIOR ISSUE OF WARRANTS - NEBARI
To consider and, if thought fit, to pass the following Resolution as an ordinary resolution:
“That, for the purposes of Listing Rule 7.4 and for all other purposes, shareholders ratify the prior issue of 166,933,764
unlisted warrants (each with an exercise price of US$0.0288 (2.88 US cents), expiring 24 November 2029 and which,
upon exercise, entitle the holder to one fully paid ordinary share in the capital of the Company) to Nebari Partners GP
III LLC as described in the Memorandum which accompanied and formed part of this Notice.”
Voting Exclusion Statement – Resolution 5
The Company will disregard any votes cast in favour of Resolution 5 by or on behalf of a person who participated in the issue or is a
counterparty to the agreement being approved or any associate of that person.
However, this does not apply to a vote cast in favour of Resolution 5 by:
• a person as proxy or attorney for a person who is entitled to vote on the resolution, in accordance with the directions given to the
proxy or attorney to vote on the resolution in that way; or
• the chair of the Meeting as proxy or attorney for a person who is entitled to vote on the resolution, in accordance with a direction
given to the chair to vote on the resolution as the chair decides; or
• a holder acting solely as nominee, trustee, custodial or other fiduciary capacity on behalf of a beneficiary provided the following
conditions are met:
o the beneficiary provides written confirmation to the holder that the beneficiary is not excluded from voting, and is not an
associate of a person excluded from voting, on the resolution; and
o the holder votes on the resolution in accordance with directions given by the beneficiary to the holder to vote in that way.
RESOLUTION 6: CONSOLIDATION OF CAPITAL
To consider and, if thought fit, to pass the following Resolution as an ordinary resolution:
“That, for the purposes of section 254H of the Corporations Act 2001 (Cth) and for all other purposes, the issued capital
of the Company be consolidated on the basis that every ten (10) fully paid ordinary shares are consolidated into one (1)
fully paid ordinary share (and that convertible securities are consolidated on the same basis (with exercise prices to be
amended on an inverse basis)) as described in the Memorandum which accompanied and formed part of this Notice.”
OTHER BUSINESS
To consider any other business that may be brought before the Meeting in accordance with the constitution of the
Company and the Corporations Act 2001 (Cth) (Corporations Act).
By the order of the Board
Simon Whyte
Joint Company Secretary and CFO
Dated: 5 March 2026
The accompanying Proxy Instructions and Memorandum form part of this Notice.
-4-
PROXY AND VOTING INSTRUCTIONS
Proxy Instructions
A member who is entitled to vote at a meeting may appoint:
• one proxy if the member is only entitled to one vote; and
• one or two proxies if the member is entitled to more than one
vote.
Where more than one proxy is appointed each proxy may be appointed
to represent a specific proportion of the member’s voting rights. If the
appointment does not specify the proportion or number of votes each
proxy may exercise, each proxy may exercise half of the votes in which
case any fraction of votes will be disregarded.
The proxy form (and the power of attorney or other authority, if any,
under which the proxy form is signed) or a copy or facsimile which
appears on its face to be an authentic copy of the proxy form (and the
power of attorney or other authority) must be lodged with the
Company’s share registry not less than 48 hours before the time for
holding the Meeting, or adjourned meeting as the case may be, at
which the individual named in the proxy form proposes to vote.
The proxy form must be signed by the member or his/her attorney duly
authorised in writing or, if the member is a corporation, in a manner
permitted by the Corporations Act. A proxy given by a foreign
corporation must be executed in accordance with the laws of that
corporation’s place of incorporation.
The proxy may, but need not, be a member of the Company.
A proxy form is attached to this Notice.
If you sign the proxy form and do not appoint a proxy, you will have
appointed the Chair of the Meeting as your proxy.
Corporate Representatives
Any corporation which is a member of the Company may authorise (by
certificate under common seal or other form of execution authorised by
the laws of that corporation’s place of incorporation, or in any other
manner satisfactory to the chairperson of the Meeting) a natural person
to act as its representative at any general meeting.
Voting Entitlement
For the purposes of the Corporations Act and Corporations Regulations
shareholders entered on the Company’s Register of Members as at
7:00pm (Melbourne time) on 6 April 2026 are entitled to attend and vote
at the meeting.
On a poll, members have one vote for every fully paid ordinary share
held. Holders of options are not entitled to vote.
How the Chair Will Vote Undirected Proxies
The Chair of the Meeting will vote undirected proxies in favour of all of
the proposed Resolutions.
-5-
WEST WITS MINING LIMITED
ACN 124 894 060
EXTRAORDINARY GENERAL MEETING
EXPLANATORY MEMORANDUM
This Memorandum has been prepared for the information of members of West Wits Mining Limited [ACN 124 894 060]
(the "Company") in connection with the business to be conducted at the Extraordinary General Meeting (“Meeting”) of
Shareholders of the Company to be held at the offices of William Buck, Level 20, 181 William Street, Melbourne VIC 3000
on 8 April 2026 at 3:00pm (Melbourne time).
Shareholders are strongly encouraged to lodge their directed proxy forms in accordance with the instructions set out
therein to vote before the Meeting.
This Memorandum should be read in conjunction with, and forms part of, the accompanying Notice. Note that all figures
are on a pre Consolidation (defined for Resolution 6) basis except where otherwise stated.
BACKGROUND TO RESOLUTIONS 1 TO 3
On 27 January 2026, the Company issued 421,750,000 fully paid ordinary shares (Placement Shares) to unrelated
sophisticated and institutional investors at $0.08 (8 cents) per Placement Share. The Placement Shares were issued under
the placement capacity available to the Company under Listing Rule 7.1 (31,983,024 Placement Shares) and Listing Rule
7.1A (389,766,976 Placement Shares). Resolution 1 seeks shareholder approval, for the purposes of Listing Rule 7.4 and
for all other purposes, to ratify the prior issue of the Placement Shares.
Every two Placement Shares were accompanied by one free-attaching unquoted (unlisted) option (Placement Option),
with 210,874,997 Placement Options being issued on 27 January 2026. Each Placement Option has an exercise price of
$0.11 (11 cents), expiry date of 27 January 2029 and, upon exercise, entitle the holder to one fully paid ordinary share in
the capital of the Company. The Placement Options were issued under the placement capacity available to the Company
under Listing Rule 7.1. Resolution 2 seeks shareholder approval, for the purposes of Listing Rule 7.4 and for all other
purposes, to ratify the prior issue of the Placement Options.
The issue of the Placement Shares and Placement Options was the result of an approach and offer accepted by the
Company as communicated by Evolution Capital Pty Ltd (Evolution), as an approach and offer that Evolution was
authorised to make on behalf of clients. As part of that approach and offer, Evolution were issued 10,000,000 options with
the same terms as the Placement Options (Broker Options) on 27 January 2026. The Broker Options were issued under
the placement capacity available to the Company under Listing Rule 7.1. Resolution 3 seeks shareholder approval, for the
purposes of Listing Rule 7.4 and for all other purposes, to ratify the prior issue of the Broker Options.
Listing Rules – Resolution 1
Broadly speaking, and subject to a number of exceptions, Listing Rule 7.1 limits the amount of equity securities that a
listed company can issue without the approval of its shareholders over any 12 month period to 15% of the fully paid
ordinary securities it had on issue at the start of that period.
The Company obtained shareholder approval at its 2025 Annual General Meeting on 20 November 2025 to issue up to
10% of its fully paid ordinary securities under Listing Rule 7.1A within the set period provided for under Listing Rule 7.1A.1.
The Placement Shares the subject of Resolution 1 were issued under the placement capacity available to the Company
under Listing Rule 7.1 (31,983,024 Placement Shares) and Listing Rule 7.1A (389,766,976 Placement Shares).
The issue of the Placement Shares the subject of Resolution 1 does not fit within any of the exceptions under Listing Rule
7.2 and, as it has not yet been approved by the shareholders of the Company, it effectively uses up part of the limit in
Listing Rules 7.1 and 7.1A, reducing the capacity of the Company to issue further securities without shareholder approval
under Listing Rules 7.1 and 7.1A.
Listing Rule 7.4 allows the shareholders of a listed company to approve an issue of equity securities after it has been made
or agreed to be made. If they do, the issue is taken to have been approved under Listing Rule 7.1 and so does not reduce
the capacity of the Company to issue further securities without shareholder approval under that rule.
-6-
The Company wishes to retain as much flexibility as possible to issue additional equity securities into the future without
having to obtain shareholder approval for such issues under Listing Rule 7.1.
To this end, Resolution 1 seeks shareholder approval of the issue of the Placement Shares under and for the purposes of
Listing Rule 7.4.
If Resolution 1 is passed, the issue of the Placement Shares will be excluded in calculating the Company’s limit in Listing
Rule 7.1 (and, if the relevant approval is held at the time, Listing Rule 7.1A) effectively increasing the number of equity
securities it can issue without shareholder approval.
If Resolution 1 is not passed, the issue of the Placement Shares will be included in calculating the Company’s limit under
Listing Rule 7.1 (and, if the relevant approval is held at the time, Listing Rule 7.1A), effectively decreasing the number of
equity securities it can issue without shareholder approval.
The following information is provided in accordance with the requirements of Listing Rule 7.5:
• The Placement Shares the subject of Resolution 1 were issued to unrelated sophisticated and institutional investors.
Investors were identified by Evolution.
• The total number of securities issued was 421,750,000 fully paid ordinary shares (Placement Shares).
• Placement Shares are fully paid ordinary shares that rank equally with the existing fully paid ordinary shares on
issue in the Company.
• The Placement Shares were issued on 27 January 2026.
• Placement Shares have an issue price of $0.08 (8 cents) each.
• The purpose of the issue of the Placement Shares was to raise approximately $33.74 million before costs. Funds
raised from issue of the Placement Shares will be applied towards:
o Qala Shallows mine development;
o Project 200 scoping study;
o BRC uranium drilling program; and
o General working capital and transaction costs.
• A voting exclusion for Resolution 1 is contained in the Notice accompanying this Memorandum.
Director recommendation – Resolution 1
The Directors recommend that shareholders vote in favour of Resolution 1.
Listing Rules – Resolution 2
Broadly speaking, and subject to a number of exceptions, Listing Rule 7.1 limits the amount of equity securities that a
listed company can issue without the approval of its shareholders over any 12 month period to 15% of the fully paid
ordinary securities it had on issue at the start of that period.
The Placement Options the subject of Resolution 2 were issued under the placement capacity available to the Company
under Listing Rule 7.1.
The issue of the Placement Options the subject of Resolution 2 does not fit within any of the exceptions under Listing Rule
7.2 and, as it has not yet been approved by the shareholders of the Company, it effectively uses up part of the limit in
Listing Rules 7.1, reducing the capacity of the Company to issue further securities without shareholder approval under
Listing Rules 7.1.
-7-
Listing Rule 7.4 allows the shareholders of a listed company to approve an issue of equity securities after it has been made
or agreed to be made. If they do, the issue is taken to have been approved under Listing Rule 7.1 and so does not reduce
the capacity of the Company to issue further securities without shareholder approval under that rule.
The Company wishes to retain as much flexibility as possible to issue additional equity securities into the future without
having to obtain shareholder approval for such issues under Listing Rule 7.1.
To this end, Resolution 2 seeks shareholder approval of the issue of the Placement Options under and for the purposes of
Listing Rule 7.4.
If Resolution 2 is passed, the issue of Placement Options will be excluded in calculating the Company’s limit in Listing Rule
7.1, effectively increasing the number of equity securities it can issue without shareholder approval.
If Resolution 2 is not passed, the issue of Placement Options will be included in calculating the Company’s 15% limit under
Listing Rule 7.1, effectively decreasing the number of equity securities it can issue without shareholder approval.
The following information is provided in accordance with the requirements of Listing Rule 7.5:
• The Placement Options were issued to unrelated sophisticated and institutional investors who subscribed for and
were issued the Placement Shares the subject of Resolution 1. Investors were identified by Evolution.
• The total number of securities issued was 210,874,997 Placement Options.
• Placement Options have an exercise price of $0.011 (11 cents), expiry date of 27 January 2029 and, upon exercise,
entitles the holder to one fully paid ordinary share in the capital of the Company. The full terms of Placement
Options are set out in Annexure A.
• The Placement Options were issued on 27 January 2026.
• The Placement Options have a nil issue price and were issued as free-attaching to Placement Shares on the basis of
one Placement Option for every two Placement Shares issued.
• The purpose of the issue of the Placement Options is as free-attaching securities to the Placement Shares, being
one Placement Option for every two Placement Shares issued. Funds raised on exercise of Placement Options (if
any) will be applied to meeting the working capital requirements of the Company at the time of exercise.
• A voting exclusion for Resolution 2 is contained in the Notice accompanying this Memorandum.
Director recommendation – Resolution 2
The Directors recommend that shareholders vote in favour of Resolution 2.
Listing Rules – Resolution 3
Broadly speaking, and subject to a number of exceptions, Listing Rule 7.1 limits the amount of equity securities that a
listed company can issue without the approval of its shareholders over any 12 month period to 15% of the fully paid
ordinary securities it had on issue at the start of that period.
The Broker Options the subject of Resolution 3 were issued under the placement capacity available to the Company under
Listing Rule 7.1.
The issue of the Broker Options the subject of Resolution 3 does not fit within any of the exceptions under Listing Rule 7.2
and, as it has not yet been approved by the shareholders of the Company, it effectively uses up part of the limit in Listing
Rules 7.1, reducing the capacity of the Company to issue further securities without shareholder approval under Listing
Rules 7.1.
Listing Rule 7.4 allows the shareholders of a listed company to approve an issue of equity securities after it has been made
or agreed to be made. If they do, the issue is taken to have been approved under Listing Rule 7.1 and so does not reduce
the capacity of the Company to issue further securities without shareholder approval under that rule.
-8-
The Company wishes to retain as much flexibility as possible to issue additional equity securities into the future without
having to obtain shareholder approval for such issues under Listing Rule 7.1.
To this end, Resolution 3 seeks shareholder approval of the issue of the Broker Options under and for the purposes of
Listing Rule 7.4.
If Resolution 3 is passed, the issue of Broker Options will be excluded in calculating the Company’s limit in Listing Rule 7.1,
effectively increasing the number of equity securities it can issue without shareholder approval.
If Resolution 3 is not passed, the issue of Broker Options will be included in calculating the Company’s 15% limit under
Listing Rule 7.1, effectively decreasing the number of equity securities it can issue without shareholder approval.
The following information is provided in accordance with the requirements of Listing Rule 7.5:
• The Broker Options were issued to Evolution Capital Pty Ltd.
• The total number of securities issued was 10,000,000 Broker Options.
• Broker Options have an exercise price of $0.011 (11 cents), expiry date of 27 January 2029 and, upon exercise,
entitles the holder to one fully paid ordinary share in the capital of the Company. The full terms of Broker Options
are set out in Annexure A.
• The Broker Options were issued on 27 January 2026.
• The Broker Options have a nil issue price and were issued as a term of the approach and offer that Evolution was
authorised to make on behalf of clients to the Company.
• The purpose of the issue of the Broker Options was as a term of the approach and offer that Evolution was
authorised to make on behalf of clients. Funds raised on exercise of Broker Options (if any) will be applied to
meeting the working capital requirements of the Company at the time of exercise.
• A voting exclusion for Resolution 3 is contained in the Notice accompanying this Memorandum.
Director recommendation – Resolution 3
The Directors recommend that shareholders vote in favour of Resolution 3.
RESOLUTION 4: RATIFICATION OF PRIOR ISSUE OF OPTIONS – ABSA
Resolution 4 seeks shareholder approval, for the purposes of Listing Rule 7.4 and for all other purposes, to ratify the prior
issue of 100,386,000 unquoted (unlisted) options (Absa Options) (each with an exercise price of $0.0185 (1.85 cents),
expiring 30 November 2030 and, upon exercise, entitle the holder to one fully paid ordinary share in the capital of the
Company) to Absa Bank Limited (acting through its Corporate and Investment Banking Division) (Absa) on 10 November
2025.
Listing Rules – Resolution 4
Broadly speaking, and subject to a number of exceptions, Listing Rule 7.1 limits the amount of equity securities that a
listed company can issue without the approval of its shareholders over any 12 month period to 15% of the fully paid
ordinary securities it had on issue at the start of that period.
The Absa Options the subject of Resolution 4 were issued under the placement capacity available to the Company under
Listing Rule 7.1.
The issue of the Absa Options the subject of Resolution 4 does not fit within any of the exceptions under Listing Rule 7.2
and, as it has not yet been approved by the shareholders of the Company, it effectively uses up part of the limit in Listing
Rules 7.1, reducing the capacity of the Company to issue further securities without shareholder approval under Listing
Rules 7.1.
-9-
Listing Rule 7.4 allows the shareholders of a listed company to approve an issue of equity securities after it has been made
or agreed to be made. If they do, the issue is taken to have been approved under Listing Rule 7.1 and so does not reduce
the capacity of the Company to issue further securities without shareholder approval under that rule.
The Company wishes to retain as much flexibility as possible to issue additional equity securities into the future without
having to obtain shareholder approval for such issues under Listing Rule 7.1.
To this end, Resolution 4 seeks shareholder approval of the issue of the Absa Options under and for the purposes of Listing
Rule 7.4.
If Resolution 4 is passed, the issue of Absa Options will be excluded
Share your feedback
Discover